[What is the real value of antiaggregation therapy in the prevention of ischemic cerebral infarction? Reflections and suggestions].
Neri Serneri
G G
GG
Gensini
G F
GF
Fortini
A
A
Amaducci
L
L
Inzitari
D
D
D001241:Aspirin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications / Q000517:prevention & control; D002544:Cerebral Infarction / Q000209:etiology / Q000517:prevention & control*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000517:prevention & control; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin
Qual'è il reale valore della terapia antiaggregante nella prevenzione dell'infarto cerebrale ischemico? Riflessioni e suggerimenti.